Protamine sulphate, heparin, and blood coagulation.
作者信息
PORTMANN A F, HOLDEN W D
出版信息
J Clin Invest. 1949 Nov;28(6 Pt 2):1451-8. doi: 10.1172/JCI102210.
Abstract
摘要
相似文献
1
Protamine sulphate, heparin, and blood coagulation.
J Clin Invest. 1949 Nov;28(6 Pt 2):1451-8. doi: 10.1172/JCI102210.
2
Comparative study of protamine chloride and sulphate in relation to the heparin rebound phenomenon.
Thromb Res. 1983 Oct 15;32(2):109-14. doi: 10.1016/0049-3848(83)90022-1.
3
Experimental studies of heparin-protamine activity with special reference to protamine inhibition of clotting.
Surgery. 1959 Dec;46:1060-8.
4
[Treatment of hyperheparinaemia with prolonged intramuscular protamine].
Prog Med (Napoli). 1951 May 31;7(10):300-6.
5
Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
Thorac Cardiovasc Surg. 2015 Aug;63(5):397-403. doi: 10.1055/s-0035-1554998. Epub 2015 Jun 29.
6
[Studies on the heparin-protamine test].
Klin Wochenschr. 1953 Apr 1;31(13-14):307-10. doi: 10.1007/BF01472084.
7
[Inhibition of heparin effects by protamine sulfate].
Orv Hetil. 1956 Jan 29;97(5):113-8.
8
[Pre- and postoperative heparin activity in gynecological surgery with protamine sulfate index and with coagulation time].
Quad Clin Ostet Ginecol. 1952 Sep;7(9):629-34.
9
Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
Thromb Haemost. 2000 Feb;83(2):334-7.
10
Use of a modified Allen protamine titration procedure in determining physiological variations of a heparin-like substance.
J Lab Clin Med. 1950 Dec;36(6):968.
引用本文的文献
1
Heparin reversal with protamine sulfate after Percutaneous Hepatic Perfusion (PHP): is less more?
Cancer Imaging. 2023 Jul 14;23(1):68. doi: 10.1186/s40644-023-00590-7.
2
The methods for removal of direct oral anticoagulants and heparins to improve the monitoring of hemostasis: a narrative literature review.
Thromb J. 2023 May 19;21(1):58. doi: 10.1186/s12959-023-00501-7.
3
Targeting heparin and heparan sulfate protein interactions.
Org Biomol Chem. 2017 Jul 21;15(27):5656-5668. doi: 10.1039/c7ob01058c. Epub 2017 Jun 27.
4
Linear polyalkylamines as fingerprinting agents in capillary electrophoresis of low-molecular-weight heparins and glycosaminoglycans.
Electrophoresis. 2011 Nov;32(21):3070-7. doi: 10.1002/elps.201100175. Epub 2011 Oct 17.
5
Surfen, a small molecule antagonist of heparan sulfate.
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13075-80. doi: 10.1073/pnas.0805862105. Epub 2008 Aug 25.
6
The action of some water-soluble poly-alpha-amino-acids on blood clotting.
Biochem J. 1951 Jun;49(1):10-7. doi: 10.1042/bj0490010.
7
Alterations in blood coagulation and hemostasis during extracorporeal circulation. II.
Can Med Assoc J. 1962 Oct 20;87(16):859-64.
8
Migration of histones from the nuclei of isolated cerebral tissues kept in cold media.
Biochem J. 1961 Jan;78(1):33-40. doi: 10.1042/bj0780033.
9
[Problems of blood coagulation in extracorporeal circulation with the heart-lung machine].
Klin Wochenschr. 1961 Feb 15;39:165-73. doi: 10.1007/BF01482946.
10
Observations on thrombin inactivation by human serum.
J Gen Physiol. 1953 Nov 20;37(2):139-56. doi: 10.1085/jgp.37.2.139.
本文引用的文献
1
The reaction of heparin with proteins and complex bases.
Biochem J. 1943 Jul;37(2):189-95. doi: 10.1042/bj0370189.
Zotero 插件